BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3792080)

  • 1. Diminished natural killer-cell activity of interstitial pulmonary cell populations from patients with carcinoma of the lung.
    deShazo RD; Moulder PV; Bozelka B; Chapman Y
    Chest; 1987 Jan; 91(1):26-8. PubMed ID: 3792080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.
    Moy PM; Holmes EC; Golub SH
    Cancer Res; 1985 Jan; 45(1):57-60. PubMed ID: 3855286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
    Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of tumor infiltrating lymphocytes.
    Holmes EC
    Ann Surg; 1985 Feb; 201(2):158-63. PubMed ID: 3155935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)].
    Xu ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):345-7. PubMed ID: 2177396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic cell function in bronchogenic carcinoma.
    Kratikanont P; deShazo RD; Banks DE; Chapman Y
    Chest; 1987 Jul; 92(1):90-4. PubMed ID: 3595254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
    Kadoyama C; Kimura H; Yamaguchi Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment].
    Mikasa K
    Jpn J Antibiot; 2000 Apr; 53(4):253-60. PubMed ID: 10868303
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postoperative sequential testing of cytotoxic activity against the autologous and allogeneic tumor cells in patients with primary lung resected cancer].
    Fujisawa T; Fukasawa T; Saitoh Y; Urabe N; Nomoto Y; Yamakawa H; Baba M; Kimura H; Yamaguchi Y
    Gan No Rinsho; 1988 Nov; 34(14):1922-6. PubMed ID: 2849685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic evaluation in patients with lung cancer with special regard to peripheral blood natural killer cell activity and interleukin-2 productivity].
    Matsuse T; Fukuchi Y; Nagase T; Suruda T; Yamaoka M; Ishida K; Harada N; Toba K; Orimo H
    Nihon Ronen Igakkai Zasshi; 1989 Sep; 26(5):475-80. PubMed ID: 2515327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The unusually favorable prognosis of multiple primary bronchial carcinoma--the consequence of natural killer cell elevation and increased interleukin 2 receptor expression?].
    Plat U; Plat M
    Z Erkr Atmungsorgane; 1989; 172(2):150-4. PubMed ID: 2787945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of smoking on human natural killer cell activity.
    Phillips B; Marshall ME; Brown S; Thompson JS
    Cancer; 1985 Dec; 56(12):2789-92. PubMed ID: 4052953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic action of natural killer cells on human tumor cells].
    Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
    Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.